Evidence map›Paper›PMID 40895177›Full record

ArticleParkinson's disease2025

Feasibility and Acceptability of Intervention and Trial Procedures of the UCL Live Well With Parkinson's Self-Management Toolkit.

Tasmin Rookes, Megan Armstrong, Kate Walters, Joy Read, Elizabeth Chesterman, Nathan Davies, Jennifer Pigott, Danielle Nimmons, Gareth Ambler, Mariam Adeleke and 4 more

Abstract read
In one paragraph

Article in Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tasmin RookesResearch Department of Primary Care and Population Health, University College London, London, UK.ORCID https://orcid.org/0000-0001-6330-7059
Megan ArmstrongResearch Department of Primary Care and Population Health, University College London, London, UK.ORCID https://orcid.org/0000-0001-6773-9393
Kate WaltersResearch Department of Primary Care and Population Health, University College London, London, UK.ORCID https://orcid.org/0000-0003-2173-2430
Joy ReadDepartment of Clinical and Movement Neurosciences, University College London, London, UK.ORCID https://orcid.org/0000-0002-3028-3975
Elizabeth ChestermanDepartment of Clinical and Movement Neurosciences, University College London, London, UK.ORCID https://orcid.org/0000-0002-8918-0436
Nathan DaviesResearch Department of Primary Care and Population Health, University College London, London, UK.ORCID https://orcid.org/0000-0001-7757-5353
Jennifer PigottDepartment of Clinical and Movement Neurosciences, University College London, London, UK.ORCID https://orcid.org/0000-0002-0951-7941
Danielle NimmonsResearch Department of Primary Care and Population Health, University College London, London, UK.ORCID https://orcid.org/0000-0002-1239-3417
Gareth AmblerDepartment of Statistical Science, University College London, London, UK.ORCID https://orcid.org/0000-0002-5322-7327
Mariam AdelekeDepartment of Statistical Science, University College London, London, UK.ORCID https://orcid.org/0000-0002-7272-2462
Rachael HunterResearch Department of Primary Care and Population Health, University College London, London, UK.ORCID https://orcid.org/0000-0002-7447-8934
Benjamin GardnerSchool of Psychology, University of Surrey, Guildford, UK.ORCID https://orcid.org/0000-0003-1223-5934
Catherine AtkinsonHomerton Healthcare NHS Foundation Trust, London, UK.ORCID https://orcid.org/0009-0001-0109-311X
Anette SchragDepartment of Clinical and Movement Neurosciences, University College London, London, UK.ORCID https://orcid.org/0000-0002-9872-6680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Managing Parkinson's disease (PD) symptoms can be challenging due to multiple factors, including complex symptoms, which are often reported late, and a lack of resources, resulting in worse outcomes. Self-management of PD symptoms is a priority for patients, their carers, healthcare staff and systems. However, there is no effective comprehensive self-management intervention for use in the United Kingdom to support people with PD to self-manage problematic symptoms. We have developed a facilitated self-management toolkit through literature reviews and co-design workshops. We conducted a single-group, pre-post feasibility study to evaluate the feasibility and acceptability of this toolkit, ahead of a randomised controlled trial (RCT). We assessed the feasibility of the study by measuring recruitment rate, retention rate, data completion, outcome measures and serious adverse events. In addition, we collected fidelity data to ensure the intervention was delivered as designed. For acceptability, we measured participants' engagement through attendance at sessions, as well as through a feedback survey completed by participants at follow-up. In a subgroup of participants, we conducted semistructured interviews to gain feedback on what participants thought was good and what could be improved with the intervention, as well as how acceptable the trial procedures were. All quantitative data were summarised descriptively, and qualitative data were analysed using codebook thematic analysis. We successfully recruited the target population within a predefined timeline, maintained intervention engagement and completed sufficient follow-up, with limited missing data and no intervention-related serious adverse events. The intervention was delivered with 93% fidelity, and 89% of participants were engaged. Participants found the supporter sessions most helpful, followed by information pages, and setting person-centred goals. Having all their PD information in one place was seen as valuable, as well as talking through their challenges and problem-solving how to overcome them. The toolkit is now being tested in a national RCT.

Identifiers

PMID40895177
PMCPMC12393956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.